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Summary
In Escherichia coli many enzymes including MurG are
directly involved in the synthesis and assembly of
peptidoglycan. MurG is an essential glycosyltrans-
ferase catalysing the last intracellular step of pepti-
doglycan synthesis. To elucidate its role during
elongation and division events, localization of MurG
using immunoﬂuorescence microscopy was per-
formed. MurG exhibited a random distribution in the
cell envelope with a relatively higher intensity at the
division site. This mid-cell localization was dependent
on the presence of a mature divisome. Its localization
in the lateral cell wall appeared to require the pres-
ence of MreCD. This could be indicative of a potential
interaction between MurG and other proteins. Inves-
tigating this by immunoprecipitation revealed the
association of MurG with MreB and MraY in the same
protein complex. In view of this, the loss of rod shape
of DmreBCD strain could be ascribed to the loss of
MurG membrane localization. Consequently, this
could prevent the localized supply of the lipid II pre-
cursor to the peptidoglycan synthesizing machinery
involved in cell elongation. It is postulated that the
involvement of MurG in the peptidoglycan synthesis
concurs with two complexes, one implicated in cell
elongation and the other in division. A model repre-
senting the ﬁrst complex is proposed.
Introduction
The characteristic shape of most bacteria is attributed to
the peptidoglycan layer. This major constituent of the bac-
terial cell wall is responsible for the maintenance of the
structural integrity of the cell by withstanding its internal
turgor pressure. The biosynthesis of peptidoglycan is
therefore essential and its role is unique to bacteria. As a
consequence, enzymes involved in this complex process
are used as targets for antibiotics. In Escherichia coli the
assembly of peptidoglycan includes three phases
(Ha et al., 2001). Phase one begins in the cytoplasm
of the bacterial cell and involves the synthesis
of UDP-N-acetylmuramyl-pentapeptide (UDP-MurNAc-
pentapeptide) from UDP-N-acetyl-glucosamine (UDP-
GlcNAc). During the second phase, which takes place on
the cytoplasmic surface of the bacterial membrane, the
activity of two essential enzymes, MraY and MurG,
is required. MraY catalyses the transfer of the phos-
pho-MurNAc-pentapeptide motif of UDP-MurNAc-
pentapeptide to a lipid carrier, undecaprenyl phosphate,
to form the so-called lipid I. MurG (a glycosyltransferase)
then catalyses the transfer of the GlcNAc motif of UDP-
GlcNAc to the C4 hydroxyl MurNAc in lipid I to produce
the lipid-linked b-(1,4) disaccharide known as lipid II. In
phase three, which is called cell surface stage, lipid II is
translocated to the exterior surface of the cell by an
unknown mechanism and incorporated into the pepti-
doglycan through transglycosylation and transpeptidation
reactions by penicillin-binding proteins (PBPs) (Höltje,
1998; Nanninga, 1998; Vollmer and Höltje, 2001).
AsMraYandMurGarekeyplayersinthebiosynthesisof
thepeptidoglycanlayer,studyingtheseimportantenzymes
could furnish insights into the development of inhibitors
and subsequently to further understand the mechanism of
the persisting problem of resistance to antibiotics. Up to
now, MurG has been the subject of several studies. It has
been shown that MurG is required for cell growth and
survival (Mengin-Lecreulx et al., 1991) and that it is
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mammalian cells, this enzyme is interesting to evaluate as
a potential antibiotic target. Recently, the crystal structure
was solved (Ha et al., 2000; Hu et al., 2003) and several
(high-throughput) assays for screening inhibitors of MurG
have been developed and validated (Auger et al., 2003;
Helm et al., 2003; Liu et al., 2003; Zawadzke et al., 2003;
Ravishankar et al., 2005; Ramachandran et al., 2006).
Although these studies have elucidated the kinetic charac-
terization of MurG, little is known about its mechanism of
action at the level of morphogenesis and in particular its
molecular interactions with other proteins.
Therefore, the aim of the present study was to provide a
cellularcharacterizationofMurGandtodetermineputative
interactions with proteins of E. coli, in an attempt to eluci-
date its speciﬁc function in relation to cell elongation and
cell division. To this end, immunoﬂuorescence microscopy
(IFM) and immunoprecipitation (IP) were applied. MurG
appeared to be randomly distributed in the cell envelope
with a relatively higher intensity at the division site. This
mid-cell localization was dependent on the presence of the
divisome. Particularly, for this position MurG required the
presence of PBP3 and FtsQ. Furthermore, the results of IP
using chemical cross-linking revealed the association of
MurG with MreB and MraY in the same protein complex.
The localization of MurG appeared also to be dependent
on the expression of the mreBCD operon. This suggests
that the defect in cell elongation caused by the absence of
MreBCD is possibly due to the inability of MurG to position
the lipid II peptidoglycan precursor.
Results
MurG is tightly associated with the cytoplasmic
membrane
Outer and inner membranes of inside-out membrane
vesicles were separated using sucrose density equilibrium
centrifugation and the presence of MurG was assessed by
immunoblotting using antibodies raised against this
protein. MurG was shown to be present in the inner mem-
brane fraction [inner membrane vesicles (IMVs)] corre-
sponding to the 45% sucrose layer. This fraction was
further used to study the characteristics of interaction of
MurG with the inner membrane. As shown in Fig. S1,
association of MurG with the inner membrane was not
affected by chemical reagents such as 2 M NaCl, and
0.1 M Na2CO3, whereas 50 mM EDTA and 6 M urea
caused a slight decrease in the intensity of the protein
band.ThisimpliesthatMurGisstronglyassociatedwiththe
inner membrane. However, MurG could be released from
the inner membrane after treatment with 1% Triton X-100
as reported (Van den Brink-van der Laan et al., 2003) and
upon subjection to trypsin digestion (Fig. S1). These
results suggest that the interaction of MurG with the
cytoplasmic membrane is predominantly of hydrophobic
nature.
MurG localizes in the lateral cell wall as well as
at the division site
The number of MurG molecules per average cell present
in cell extracts of E. coli LMC500 (wild-type K-12) grown
to steady state at 28°C in GB1 medium was determined
by immunoblotting and densitometrical comparison of the
MurG signal from the cell extract (total lysate) with that of
a concentration gradient of puriﬁed MurG. MurG was esti-
mated to be present in 1200  33 (n = 3) molecules per
average cell (see Fig. S2).
CellularlocalizationofMurGinLMC500grownat28°Cin
GB1 and TY was examined by IFM. MurG localized as
multipledistinctfociinthecellenvelope(Fig. 1A).Because
MurG was mostly present in the inner membrane but
almost absent in the cytosol as shown by immunoblotting
(seeFig. S3),thefocimustrepresentenvelope-associated
MurG. Analysis of the normalized average ﬂuorescence
intensity proﬁle (FIP) of a total of more than 500 LMC500
cells revealed a random ﬂuorescence distribution of MurG
in the cell envelope with a relatively higher intensity at the
division site (Fig. 2). The intensity increase at mid-cell was
not a result of the constriction, i.e. doubling of membranes
(compare with the FIP of a general lipid stain of the mem-
branes with BODIPY-C12 in ﬁg. 8A of Bertsche et al.,
2006). In addition to this mid-cell localization of MurG in
TY-grown cells, a denser distribution at predivision sites
(i.e. 1/4 and 3/4 positions) of the future daughter cells
(Fig. 2B)wasvisible.Thisisconsistentwiththeproposition
of random incorporation of precursors of peptidoglycan in
E. coli during lateral growth with a higher synthetic activity
at the middle of the cell before a constriction was visible
(Taschner et al., 1988b; Wientjes and Nanninga, 1989).
The cellular localization of MurG was also studied in the
MurG temperature-sensitive (Ts) strain GS58 (Salmond
et al., 1980), which expresses a non-functional truncated
MurG (amino acids 1–290) at 42°C due to an amber
mutation at W290 (at the restrictive temperature a STOP
replaces the W290 tryptophan present in the wild-type
strain (Crouvoisier et al. to be published elsewhere)).
These cells grow well at 28°C in TY and show a normal
MurG localization pattern (Fig. 1B) but after a shift to 42°C
for 2 mass doublings (MDs) they become abnormally wide
and swollen and ﬁnally they start to lyse. At this restrictive
temperature,MurGwasevenlydistributedinthecytoplasm
and mid-cell localization was not detectable (Fig. 1C). The
non-functional truncated MurG could be detected by the
used antibody when immunoblotting was performed. The
absence of membrane localization was therefore not due
to insufficient recognition of MurG by the antibody. This
indicatesthatthecarboxy-terminal66aminoacidsofMurG
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they may interact with membrane components or because
their absence may affect the folding of MurG.
Mid-cell localization of MurG requires divisome
components
To investigate whether the presence of MurG at mid-cell
was division dependent, its localization was studied in the
strain LMC509 that expresses the temperature-sensitive
FtsZ84(Ts) protein, which is not able to polymerize at
mid-cell and causes ﬁlamentation at the restrictive tem-
perature (Addinall et al., 1997). MurG showed normal
mid-cell localization in this strain at 28°C (Fig. 3A).
However, at 42°C MurG foci were randomly distributed in
the cell envelope (Fig. 3B). This suggests that the mid-cell
localization of MurG is related to cell division. The earliest
event in cell division is the assembly of the FtsZ-ring. This
is followed by the assembly of a number of other cell
division proteins at mid-cell about 1/5 of a generation time
later just before the onset of the constriction process
(Aarsman et al., 2005). To examine whether the MurG
mid-cell localization is dependent on an early or a late
event in the process of cell division, localization studies of
Fig. 1. Localization of MurG in wild-type
E. coli LMC500 (A) and in the MurG(Ts) strain
GS58 (B and C). Phase-contrast images are
given on the left and ﬂuorescence images on
the right. LMC500 cells were grown to steady
state at 28°C in GB1 (A), ﬁxed, permeabilized
and immunolabelled with anti-MurG. GS58
cells were ﬁrst grown to mid-exponential
phase at 28°C in TY medium (B) shifted to
42°C and allowed to grow for 2 MDs (C).
Thereafter they were ﬁxed, permeabilized and
subjected to MurG IFM. The arrows point to
the band at mid-cell. All panels have the
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contains the ftsI2158 that expresses a PBP3(Ts) protein.
PBP3 is involved in peptidoglycan synthesis and localizes
to the division site during the later stages of cell growth
and throughout septation (Weiss et al., 1999; Aarsman
et al., 2005). At 42°C the PBP3(Ts) ﬁlaments showed
blunt constriction where mid-cell localization of MurG was
not observed (Fig. 3C and Fig. S4A). This implies that the
position of MurG is dependent on the presence of PBP3.
For its recruitment to the division site it was described in
several studies (reviewed in Errington et al., 2003) that
PBP3 requires the presence of other proteins (i.e. FtsL,
FtsB, FtsQ and FtsW). FtsQ localization is believed to be
indispensable for the recruitment to the divisome of the
majorityofthelatelocalizingproteins.Toverifywhetheritis
also important for the positioning of MurG, localization of
this latter was examined in the temperature-sensitive
LMC531 strain that expresses FtsQ(Ts) in which glutamic
acid (E) 125 is replaced by a lysine (K) (Storts and Marko-
vits, 1991).At the restrictive temperature, immunolabelling
of the LMC531 ﬁlaments with anti-MurG revealed the
absence of MurG at 1/4 and 3/4 positions. Besides, a
dense ﬂuorescent signal at mid-cell was not visible
(Fig. S4B) [absence of MurG mid-cell localization was also
observed in the FtsW(Ts) strain (data not shown)]. This
indicates that the position of MurG depends on the local-
izationofFtsQandevidentlyonamaturedivisome.Togain
moreinsightinthenatureofthisreliance,MurGlocalization
in LMC500 was determined in the presence of aztreonam,
aspeciﬁcinhibitorofPBP3.Thiswasundertakentoﬁndout
whether the appearance of MurG required the function of
PBP3. Mid-cell localization of MurG was preserved in
aztreonam-induced ﬁlaments after 2 MDs (Fig. 3E see the
distinct peak at mid-cell, and Fig. S4C).As reported previ-
ously (Den Blaauwen et al., 2003), most cell division pro-
teins (including PBP3) are able to localize at mid-cell in the
presence of aztreonam for at least 2 MDs, whereas the
localization at future division sites at 1/4 or 3/4 positions is
inhibited. MurG followed this pattern suggesting that the
presence of MurG at mid-cell takes place even if the
divisome is not functional.
MurG associates with MreB in a protein complex
As alluded to above MurG seems to form a complex with
proteins that are part of the divisome. Therefore, it is
possible that it could also interact, because of its localiza-
tion in the cell envelope with proteins involved in lateral
envelope synthesis. To assess this, IP experiments were
carried out.
Membrane fractions prepared from E. coli LMC500
strain grown at 28°C in GB1 or at 37°C in TY were Triton
X-100 solubilized, chemically cross-linked with the
Fig. 2. Fluorescence intensity proﬁles of LMC500 cells grown at
28°C in TY (A and B) or in GB1 (C and D) and immunolabelled
with anti-MurG. The average normalized cell length is given on the
x-axis. The average normalized ﬂuorescence intensity (AU) is
reﬂected on the y-axis. Fluorescence intensity was determined in
cells (n  500) that have no visible constriction (A and C) and in
constricting cells (B and D). To indicate the background
ﬂuorescence (unspeciﬁc binding of secondary antibody), the
immunolabelling procedure was carried out with LMC500 cells
where the incubation with the ﬁrst antibody (anti-MurG) was omitted
(E). Proﬁles were measured using Object-image as described in
Experimental procedures.
Fig. 3. Fluorescence intensity proﬁles of LMC509 (FtsZ(Ts), A and
B), LMC510 (PBP3(Ts), C), LMC531 (FtsQ(Ts), D) and LMC500
(wild-type, E) cells. After growth at 28°C in 1/2 GB1 LMC509 cells
were shifted to 42°C for 2 MDs, and immunolabelled with anti-MurG
(A, 28°C) and (B, 42°C). LMC510 and LMC531 cells were grown at
28°C in GB1 to steady state and shifted to 42°C for 2 MDs, and
immunolabelled with anti-MurG. LMC500 cells were grown at 28°C
in GB1 after which aztreonam was added and growth was
continued for 2 MDs before the cells were immunolabelled with
anti-MurG (E). Similar patterns shown in A were also obtained for
the other temperature-sensitive strains when grown at 28°C in
GB1. The average normalized cell length is given on the x-axis.
The y-axis represents the average normalized ﬂuorescence
intensity.
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(DSP), immunoprecipitated using affinity-puriﬁed anti-
MurG IgG-coated magnetic beads, and analysed by
immunoblotting using anti-MurG. Under non-reducing
conditions (sample buffer without b-mercaptoethanol,
incubation at 37°C for 5 min before electrophoresis), the
results showed that MurG was cross-linked into a high-
molecular-weight complex. This protein complex is visible
among a smeared background in wild-type LMC500
(Fig. 4A, lane 1). The dominant bands of this complex
have a molecular weight of approximately 250 kDa and
120 kDa (Fig. 4A, lane 1). The band at the position of
about 37 kDa is free MurG (that is not completely cross-
linked in the complex). To ensure use of equal amounts of
materials, a fraction of the membranes was loaded on
SDS-PAGE and analysed with anti-MurG. The blot
depicted in Fig. 4 (lanes 1 and 2) represents 1/10 of the
membrane fraction used for the IP.
Complexes at the position of 250 kDa and around
120 kDa were likewise obtained when the immunoblot
was probed with anti-MreB (Fig. 4A, lanes 1 and 2). Con-
ducting the IP procedure with magnetic beads coated with
affinity-puriﬁed anti-MreB yielded the presence of a
protein complex as detected with anti-MurG and anti-
MreB with a comparable high molecular weight as well
(Fig. 4B, lanes 1, 2, 6 and 7), indicating that the MurG-
containing protein complex could also be immunoprecipi-
tated with MreB.
To exclude the possibility that the presence of the
250 kDa protein complex could be the result of cross-
reactivity of the secondary antibodies with IgG from the
beads, the IP procedure was conducted without the addi-
tion of the membrane fraction. As depicted in Fig. 4 (A:
lanes 5 and 10, B: lanes 5 and 10) immunoblotting with
anti-MurG or anti-MreB, respectively, did not yield any
product. In addition, controls consisting of incubating the
blots with only the secondary antibody to monitor the
potential presence of IgG on the blot conﬁrmed the
absence of protein bands and hence background binding
(Fig. S5A and B). Moreover, the complex was absent
when IP was performed with either anti-MurG or anti-
MreB of the membrane fraction of the mreBCD deletion
strain PA340-678 (Fig. 4A, lanes 3 and 8, Fig. 4B, lanes 3
and 8) in which MurG is also cytosolic (see next section
and Fig. S3) and of the MurG(Ts) strain GS58 (Fig. 4A,
lanes 4 and 9, Fig. 4B, lanes 4 and 9). Taken together, the
results provide evidence for association of MurG and
MreB in the same protein complex at the periphery of the
membrane of E. coli.
To assess whether this interaction was speciﬁc, the IP
procedure with the membrane fraction was carried out with
anti-FtsZ and the immunoblot was probed with anti-FtsZ.
Although FtsZ is thought to be predominantly a cytosolic
protein, Koppelman et al. (2004) have demonstrated that
inside-out cytoplasmic membrane vesicles (IMV) contain a
fractionofcytoplasmicmembrane-boundFtsZ(IMV–FtsZ).
The results of this IP revealed the presence of only one
band of ~40 kDa at the position of FtsZ (Fig. 4C, lanes
3–5). This band was observed in the presence (Fig. 4C,
lane 3), and absence (Fig. 4C, lane 4) of the cross-linker
undernon-reducing(lanes3and4)orreducing(incubation
at 100°C for 10 min in sample buffer containing
b-mercaptoethanol before electrophoresis) conditions
(lane 5). Hence, the absence of high-molecular-weight
complexes could be explained by the effect of treatment
withTritonX-100thatmayhavedisruptedallinteractionsof
Fig. 4. Immunoblotting (IB) analysis of the protein complex with anti-MurG and anti-MreB. IP was performed on Triton X-100 solubilized
membranes prepared from wild-type E. coli cells (LMC500), the MraY–b-lactamase–His fusion protein expression strain
BW25113DmraY/pMAKmraYec, the DmreBCD mutant PA340-678 cells, the MurG(Ts) strain GS58, and cross-linked with DSP. The detection
was carried out with anti-MurG (A, lanes 1–5, and B, lanes 1–5) or anti-MreB (A, lanes 6–10, and B, lanes 6–10). The protein complex is
visible among a smeared background in LMC500 (A, lanes 1 and 6). The dominant bands of this complex have a molecular weight of about
120 kDa and approximately 250 kDa. In the strain BW25113DmraY/pMAKmraYec (A, lane 2) the 120 kDa band is more pronounced. The band
at the position of 37 kDa is free MurG. No protein complex was yielded in the control where the IP procedure was carried out without the
membrane fractions (A, lanes 5 and 10). The same complexes (of 250 kDa and 120 kDa) are also seen when the immunoblot was probed
with anti-MreB (A, lanes 6 and 7 respectively). In the strain DmreBCD PA340-678 the protein complex is absent (A, lanes 3 and 8) and only
free MurG is visible at the level of about 37 kDa when the detection is carried out with anti-MurG (A, lane 3). The complexes of 250 kDa and
120 kDa were undetectable in the MurG(Ts) strain GS58 (A, lanes 4 and 9). The protein band of about 37 kDa is free MurG. Performing the IP
with anti-MreB resulted as well in a protein complex of approximately 250 kDa and 120 kDa in LMC500 when probing with anti-MurG or
anti-MreB (B, lanes 1 and 6 respectively). The 120 kDa band was more pronounced in the strain BW25113DmraY/pMAKmraYec (B, lanes 2
and 7). The complex was not visible in the DmreBCD PA340-678 cells (B, lanes 3 and 8). In this strain only a MurG band at the position of
37 kDa was detected when probing with anti-MurG (B, lane 3). In the MurG(Ts) the protein complex was absent (B, lanes 4 and 9). A faint
MreB band is visible when anti-MreB was used for detection (B, lane 9). To assess background binding of the secondary antibodies the
incubation with the primary antibodies was omitted from the procedure. As depicted in Fig. S5 (see Supplementary materials) no protein bands
are detected. One tenth of the membrane fraction used for the IP experiments was applied (without cross-linking) on SDS-PAGE and probed
with anti-MurG (C, lanes 1 and 2). In LMC500 and BW25113DmraY/pMAKmraYec the intensity of the band (corresponding to MurG) is
comparable (lanes 1 and 2 respectively). The interaction between MurG and MreB is speciﬁc. To show this the IP procedure with the
membrane fraction was performed with anti-FtsZ and the immunoblot was probed with anti-FtsZ. Only a band (~40 kDa) at the position of FtsZ
is detectable in the presence (lane 3) and absence (lane 4) of DSP under non-reducing (lanes 3 and 4) or reducing (lane 5) conditions. The
molecular weight of MurG, MreB and MraY–b-lactamase–His is 37.8, 36.9 and 71 kDa respectively. The data are representative of at least
three separate experiments. Although some samples were not run in the same gel, the IB procedure (i.e. electrophoresis, blotting and ECL
detection conditions) was the same for all of them.
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ciation of MurG with FtsZ (as MurG was not detected).
Additionalcontrolexperimentswerealsoperformedinvolv-
ing IP with anti-PBP1B. PBP1B is a bitopic membrane
protein that catalyses the transglycosylation and transpep-
tidation of precursors in peptidoglycan synthesis (Höltje,
1998; Vollmer and Höltje, 2001). Western blot analysis of
theIPdidnotyieldanyproteincomplexcontainingMurGor
MreB (results not shown). Based on the above described
IP experiments and controls it can be concluded that the
association of MurG with MreB was speciﬁc.
MurG associates with MraY in a protein complex
MraY catalyses the transfer of the phospho-MurNAc-
pentapeptide motif from UDP-MurNAc-pentapeptide to
undecaprenyl phosphate leading to the formation of
undecaprenyl-pyrophospho-MurNAc-(pentapeptide) (lipid
I). MurG then transfers the GlcNAc motif from UDP-
GlcNAc onto the lipid I, forming the disaccharide
derivative undecaprenyl-pyrophospho-GlcNAc-MurNAc-
(pentapeptide) (lipid II) (Bouhss et al., 2004). Lipid II is
then polymerized and cross-linked into peptidoglycan by
MurG complex for peptidoglycan synthesis 1111
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PBPs. As MraY and MurG are consecutively involved in
the same biosynthetic pathway, it was reasoned that an
interaction between these two proteins could exist. To
investigate this assumption IP was performed with mem-
brane fractions prepared from the strain BW25113DmraY/
pMAKmraYec using affinity-puriﬁed anti-MurG. In this
strain the endogenous mraY gene is deleted and comple-
mented by an MraY–b-lactamase–His fusion protein
expressed from plasmid. This strain was used due to the
lack of antibodies directed against MraY.
Probing the immunoblot with anti-MurG resulted in
cross-linked products among a smeared background.
The prominent protein band of these products had a size
of about 120 kDa (Fig. 4A, lane 2 and Fig. 5, lane 2).
This band was also detected with anti-MreB (Fig. 4, lane
2 and Fig. 5, lane 4). Performing the analysis with a
polyclonal antibody directed against b-lactamase (to
detect the MraY of E. coli in fusion with b-lactamase)
revealed the presence of a band with a molecular weight
of around 120 kDa in addition to a 70 kDa band that
corresponded to the molecular weight of MraY–b-
lactamase–His fusion (Fig. 5, lane 6). As the complex
was analysed under non-reducing conditions on SDS-
PAGE, it might be of importance to mention that the
molecular weight of the complexes might slightly diverge
from the genuine mass of the separate proteins forming
the complex. The 250 kDa complex could also be
detected although the intensity of this band is much less
than the cross-linked product in wild-type LMC500 strain
and almost indistinguishable from the background. This
difference might be attributed to the fact that LMC500
and BW25113DmraY/pMAKmraYec are distinct strains.
Control experiments where the same IP procedure was
carried out without the membrane fractions yielded no
products (Fig. 5, lanes 1, 3 and 5) indicating that MurG
and MraY interact. As a whole these ﬁndings suggest
that MurG, MreB and MraY were cross-linked in the
same protein complex.
Localization of MreB does not require the presence
of MurG
Interaction of MurG and MreB also raised the question
whether they are dependent on each other for their sub-
cellular localization. To elucidate this, the following IFM
experiments were conducted.
Prior to performing localization studies of MreB with
IFM, the presence of MreB on the IMVs was assayed
following the same procedure as aforementioned for
MurG. Using affinity-puriﬁed anti-MreB antibody, the pres-
ence of MreB was detected mainly in the cytosol and in
the inner membrane fractions. Unlike MurG, MreB could
be extracted from the IMVs after treatment with 6 M urea
or 0.1% Triton X-100 but not with 50 mM EDTA, 2 M NaCl
or 0.1 M Na2CO3 (data not shown), pointing to an asso-
ciation of this protein with the inner membrane.
In wild-type K-12 strains MreB forms a regular, dynamic
helix lying underneath the cytoplasmic membrane (Shih
et al.,2005).VisualizationofMreBwithIFMwascarriedout
in the MurG(Ts) strain GS58 to ﬁnd out whether its local-
ization relies on the presence of functional MurG. Cells
grownat28°CinTYdisplayednormalrod-shapeandMreB
localized in a helical pattern as was observed before
Fig. 5. Immunoblotting (IB) analysis of the protein complex with anti-MurG, anti-MreB and anti-b-lactamase under non-reducing conditions.
The membranes extracted from BW25113DmraY/pMAKmraYec strain (MraY–b-lactamase–His expressing strain) were used for the IP (with
cross-linking) with anti-MurG. The blot was then probed with anti-MurG (lanes 1 and 2), anti-MreB (lanes 3 and 4) or anti b-lactamase (lanes 5
and 6). In parallel the same IP was performed without the membrane fraction (lanes 1, 3 and 5). A cross-linked product with a molecular
weight of about 120 kDa is visible in all samples except in control samples (lanes 1, 3 and 5). The faint band in lane 2 is MurG, which is not
completely cross-linked in the protein complex. The band in lane 6 with the molecular weight of approximately 70 kDa corresponds to the
MraY–b-lactamase–His protein that is not completely cross-linked in the protein complex.
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helical structure was preserved regardless of the aberrant
shape of the cells (Fig. 6A). Apparently, localization of
MreB does not require the presence of a functional MurG.
Is localization of MurG dependent on the presence
of MreB?
Conversely, to demonstrate whether localization of MurG
is dependent on the presence of MreB, IFM experiments
targeting MurG were performed with the strain PA340-
678. This strain possesses a spherical morphology due to
the deletion of the mreBCD operon (Wachi et al., 1987).
MreB localizes in a helical pattern in the parental strain
PA340, but is absent in the DmreBCD deletion strain
PA340-678 (see Fig. S6). Interestingly, the localization of
MurG was cytosolic (Fig. 6B, b) like the localization
pattern observed in the MurG temperature-sensitive strain
GS58 (Fig. 1C). In addition, a discernible packed (arcked
ﬁlamentous) localization of MurG in constricting cells at
Fig. 6. Localization of MreB in the MurG(Ts)
strain GS58 grown at the restrictive
temperature (42°C) in TY for 2 MDs (A). The
MreB helical structure was maintained in the
absence of the functional full-length MurG
protein. (See for MurG localization in these
cells Fig. 1C.) MurG localization in the
absence of MreB helix (B). IFM was
performed with PA340 (wild type) and
PA340-678 (DmreBCD) cells grown at 28°C in
TY to mid-exponential phase. MurG localizes
as multiple foci in the cell envelope and at
mid-cell in the wild-type strain (a) and is
evenly distributed in the cytoplasm with no
clear mid-cell localization in the DmreBCD
strain, although a packed localization is visible
(b). Phase contrast (left) and ﬂuorescence
images (right) are shown. The image contains




MurG complex for peptidoglycan synthesis 1113
© 2007 The Authors
Journal compilation © 2007 Blackwell Publishing Ltd, Molecular Microbiology, 65, 1106–1121the position of the future constriction sites was also
observed. Apparently, this could reﬂect the presence of
MurG that is part of the divisome and required by the
division process in these cells.
In the parental wild-type strain PA340 MurG exhibited a
normal localization as multiple foci in the cell envelope
(Fig. 6B, a). As PA340-678 cells are round, it is possible
that the observed abnormality in MurG localization pattern
was due to the aberrant cell morphology rather than to the
absence of the MreB helix. To test whether the localization
of MurG would be maintained in spherical cells exhibiting
a helical arrangement pattern of MreB, LMC500 cells
were grown for 2 MDs in the presence of 2 mgm l -1 of the
PBP2 inhibitor mecillinam (Park and Burman et al., 1973).
Afunctional PBP2 is essential for length growth and main-
tenance of the diameter of the cells (Den Blaauwen et al.,
2003). Therefore inhibition of PBP2 by its speciﬁc inhibitor
mecillinam results in spherical growth. The round cells
were subsequently labelled with anti-MurG and anti-
MreB. Both patterns of MreB and MurG localization were
similar to those observed in rod-shape wild-type E. coli
(Fig. 7A and B respectively, see also Fig. S7). This indi-
cates that MurG does not require a rod-shape cell mor-
phology for a proper localization, and that cytosolic
localization visualized in round DmreBCD cells is most
likely due to the absence of the Mre proteins rather than to
the altered cell morphology.
To determine whether the absence of the MreB helix
was responsible for the anomalous MurG localization,
IFM experiments with the strain PA340-678 pMEW1 (har-
bouring the pMEW1 plasmid that expresses MreC and
MreD constitutively) was performed. This revealed a
Fig. 7. MurG and MreB localization are
independent of the spherical cell morphology
(A and B). LMC500 cells were grown for
2 MDs in the presence of mecillinam (inhibitor
of PBP2), at 28°C in GB1. Cells were
immunolabelled with anti-MreB (A) or
anti-MurG (B). The MreB helical structure is
preserved and the multi-foci localization
pattern of MurG is observed. Arrangement of
MurG is dependent on the presence of
MreCD (C). IFM was performed with
PA340-678pMEW1 strain (mreBCD deletion
strain with the pMEW1 plasmid that
expresses MreC and MreD constitutively)
grown at 28°C in TY to mid-exponential
phase. In these spherical cells MurG localized
normally as multiple foci in the cell envelope
and at mid-cell. Phase contrast (left) and
ﬂuorescence images (right) are shown. Scale
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MurG (Fig. 7C). To provide more evidence for this obser-
vation, localization of MurG was examined in wild-type
E. coli treated with A22. This molecule was described to
be a speciﬁc inhibitor of MreB (Iwai et al., 2002). It was
also reported that addition of A22 induces spherical cell
form by inhibiting cell elongation (Iwai et al., 2004). MreB
is not able to localize in these cells (Karczmarek et al.,
2007). The arrangement of MurG in E. coli cells treated
with 40 mgm l -1 of A22 for 2 and 3 MDs was not altered
(data not shown), denoting that its arrangement is depen-
dent on the presence of MreC and MreD rather than on
the presence of MreB. This is consistent with the results
published very recently, while revising this manuscript
(Aaron et al., 2007) where the cell wall synthesis in Cau-
lobacter crescentus was studied with special emphasis to
the role of FtsZ, MurG and MreB. The authors demon-
strated that MurG accumulated near mid-cell. This accu-
mulation took place shortly after the formation of the FtsZ
ring and before constriction. This underlines a high syn-
thesis and thereby availability of lipid II peptidoglycan
precursors at the FtsZ ring location. It was also shown that
mid-cell accumulation of MurG depended on FtsZ but not
on MreB or the presence of substrate.
Discussion
The present work was conducted in an attempt to get
more insights in the speciﬁc function of MurG in relation to
cell elongation and cell division. Particularly, a cellular
characterization of MurG was conducted and its putative
interactions with other proteins of E. coli were studied.
Subcellular localization of MurG
MurG catalyses the last intracellular step of peptidoglycan
synthesis (Mengin-Lecreulx et al., 1991). This glycosyl-
transferase was reported to be associated with the cyto-
plasmic face of the inner membrane (Bupp and
Heijenoort, 1993; van den Brink-van der Laan et al.,
2003). As presented here, this interaction was not or
slightly affected by the presence of high salts, alkaline
conditions, chelating agents or strong reagents. The asso-
ciation of MurG with the inner membrane could only be
disrupted after treatment with 1% Triton X-100 or trypsin,
indicating that it is predominantly of hydrophobic nature.
This is in accordance with the proposal of Hu et al. (2003),
who deduced from the crystal structure of MurG that the
membrane association site of this protein consists of a
hydrophobic patch in the N-domain surrounded by basic
residues.
Immunoﬂuorescence microscopy studies demonstrated
that MurG was randomly distributed in the cell envelope
with a higher intensity at the division site. The concen-
trated presence of MurG at the division site supports the
results published earlier by Wientjes and Nanninga
(1989). Using two different and independent approaches,
i.e. pulse-labelling of synchronized cultures and autorad-
iography of pulsed cells, the authors showed an increased
localized peptidoglycan synthesis activity at the (potential)
division sites. Based on immunodetection and electron
microscopy techniques, a localized insertion of pepti-
doglycan precursors in the cylindrical cell wall and a com-
plete new synthesis of the cell poles were observed by De
Pedro et al. (1997). Because of its dual localization, MurG
is probably essential for both the poles and the cylindrical
part of peptidoglycan synthesis. A number of MurG 50–20
foci per average cell could be estimated. With approxi-
mately 1200 MurG molecules per cell of which about 1000
are membrane bound (see Fig. S3), each focus could
contain between 20 and 50 MurG molecules. Therefore,
the random disposition of MurG in the cell envelope
seems to concur with the idea that the insertion of precur-
sors in the lateral wall occurs at a limited number of
discrete but probably dynamic sites.
In the temperature-sensitive strain of MurG (GS58) an
even distribution of MurG in the cytosol was visible. The
fact that most of these cells underwent lysis after 2 MDs at
42°C emphasizes the involvement of MurG in the synthe-
sis of peptidoglycan.
Prior to division, a mature divisome has to be
assembled at the middle of the E. coli cell. This assembly
is believed to be a multistep process. Previously, Aarsman
et al. (2005) reported on that the recruitment of the divi-
some components follows a two-step model: the ﬁrst step
involved the formation of the Z-ring by polymerization of
FtsZ at the constriction site and simultaneous localization
of ZipA, FtsA and ZapA. During the second step FtsQ,
FtsL/B, FtsW, PBP3, FtsN and AmiC are recruited to the
constriction site.
The mid-cell localization of MurG was shown to be
dependent on the presence of the mature divisome as
revealed by the results of the localization studies per-
formed with the FtsZ84(Ts) LMC509, FtsQ(Ts) LMC531,
PBP3(Ts) LMC510 strains, and with the wild-type
LMC500 cells in the presence of PBP3 inhibitor
aztreonam. Mid-cell localization of MurG was not
observed in the absence of either the ﬁrst step or the
second step proteins. These ﬁndings implicate that MurG
might be a component of the divisome. This observation
supports a model proposed previously by Nanninga
(1998) where MurG was considered to be an essential
part of the divisome. In this model the divisome is thought
to be composed of subassemblies connected via FtsZ
polymers. In each divisome subassembly proteins from
the cytoplasm and periplasm are structurally connected
(Nanninga, 1998). In light of this, it can be proposed that
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for division by being part of the divisome subassemblies.
Based on the average number of cell division proteins per
cell (Nanninga, 2001), an amount of about 50 subassem-
blies could be present. This could clarify the intense ﬂuo-
rescence signal of MurG observed at mid-cell.
Interaction of MurG, MreB and MraY proteins
Using DSP as the cross-linker a high-molecular-weight
protein complex; comprising two subcomplexes of
approximately 250 kDa and 120 kDa; was identiﬁed in
E. coli. This complex contained both MurG and MreB. The
protein complex was also detectable, although in a
reduced amount, when DSP was not employed. Taken
together, the results suggest that MurG and MreB asso-
ciate with each other. This was further conﬁrmed by the
absence of this complex in cells where mreBCD was
deleted. In addition, the absence of any unspeciﬁc (or
background) binding in control experiments provided
additional evidence for the speciﬁcity of this association.
When IP experiments were undertaken with the MraY–
b-lactamase–His fusion protein expressing strain, a main
high-molecular-weight cross-linked product was seen.
This MurG-containing band was also shown to contain
MreB and MraY–b-lactamase–His suggesting the exist-
ence of an interaction between these three proteins. As
MreB localization was shown not to be dependent on
MurG, MraY might be the linking factor of MurG and MreB.
The signiﬁcance of the formation of this multiprotein
complex could be implicated in regulation of lateral pep-
tidoglycan synthesis and thereby of cell elongation. Inter-
action of MraY and MurG may be essential for
consecutive fulﬁlling of their function in the peptidoglycan
assembly. Given the fact that the molecular weight of
these three proteins together is about 115 kDa
(MurG ª 38, MreB ª 37, MraY ª 40 kDa), it is probable
that the 250 kDa complex encompasses (in addition to the
possibility that some proteins may form oligomers) other
proteins like RodA and PBP2 that are believed to be
speciﬁcally involved in cell elongation (see the model
proposed below).
Inability of MurG to localize peptidoglycan precursors in
the DmreBCD strain might explain its spherical
morphology
Association of MurG and MreB raised the question
whether they are dependent on each other with respect to
their subcellular localization. To exhibit a helical pattern,
localization of MreB was not dependent on the presence
of MurG. In contrast, MurG was not able to localize in the
DmreBCD strain. As MurG was able to appear at its posi-
tion when only MreB was absent, it was apparent that its
localization might be dependent on the presence of the
MreC and MreD. The dependency of localization of MurG
on the presence of the MreCD could indicate that these
proteins cooperate during the elongation process in par-
ticular the lateral cell wall synthesis. In this regard, the
loss of rod shape of mreBCD deletion strain could be
caused by the loss of MurG membrane localization. As a
consequence, this could prevent the localized supply of
the lipid II precursor to the peptidoglycan synthesizing
machinery involved in cell elongation. However, the
absence of MreB led also to altered morphology (spheri-
cal cells) where the MreB helix is invisible. This can be
explained as follows: because the MreB helical structure
is affected by the absence of either MreC or MreD (Kruse
et al., 2005), it can be postulated that MreB might be
involved in the organization of these two proteins in the
cell membrane and that this MreBCD complex interacts
(cooperates) with other proteins (e.g. MraY and MurG) to
provide precursors to build the lateral peptidoglycan, and
thereby controlling the topography of cell wall
morphogenesis. Provided that MreB is essential for rod
shape in E. coli and in light of the results found by IP, a
potential (direct or indirect) association of MurG with MreB
through MraY may exist.
Model involving the role of MurG in the synthesis
of peptidoglycan
Recently, a model in which MreB, C and D form an essen-
tial membrane-bound complex that directs longitudinal
cell wall synthesis has been proposed for E. coli (Kruse
et al., 2005). Using a bacterial two-hybrid system, asso-
ciation of MreC with both MreD and MreB was demon-
strated whereas no interaction of MreB with MreD was
found (Kruse et al., 2005). In this complex a possible
interaction of MreC with multiple PBPs (which are known
to add precursors to the existing peptidoglycan by a com-
bination of transglycosylation and transpeptidation reac-
tions), including PBP2 was suggested as was previously
reported for Bacillus subtilis (Daniel and Errington et al.,
2003; Van den Ent et al., 2006) and Caulobacter crescen-
tus (Divakaruni et al. 2005). Therefore, the authors pro-
posed a model where the MreBCD complex was
predicted to interact with PBP2 and RodA (Kruse et al.,
2005). In the present work, MurG required the presence of
MreCD and not of MreB to ﬁnd its position. Therefore, it
can be reasoned that it might interact with MreCD and
hence acts in concert with the MreBCD complex in gov-
erning the morphogenesis of E. coli.
In conclusion, based on the ﬁndings described here and
onpreviousreports(Kruseet al.,2005),itcanbeproposed
that the involvement of MurG in the peptidoglycan synthe-
sis of E. coli concurs with a two-complex model. In the ﬁrst
complex, which is implicated in cell elongation MurG inter-
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PBP2(Fig. 8).Inthesecondcompleximplicatedindivision
MurG associates with other cell division proteins like FtsA,
FtsQ, FtsW and PBP3. The high-molecular-weight classA
PBPs, PBP1Aand PBP1B, are essential for peptidoglycan
synthesis (they possess transglycosylation as well as
transpeptidation activity). PBP1A and PBP1B were pro-
posed to play distinct roles in the synthesis of the cell wall
where involvement of PBP1B peptidoglycan synthesis
speciﬁc for division was suggested (Del Portillo and de
Pedro, 1990). In addition, a direct interaction between
PBP1B and PBP3 at the division site was recently demon-
strated (Bertsche et al., 2006) and PBP1A and PBP1B do
not form a complex (Charpentier et al., 2002).Therefore, it
can be speculated that PBP1A might belong to the ﬁrst
complex and PBP1B belong to the second complex of the
model. However, further studies are needed to investigate
how protein interactions (involving MurG) regulate cell
elongation and cell division.
Experimental procedures
Strains and growth media
Escherichia coli K-12 cells were grown to steady state in
glucose minimal medium (GB1) containing 6.33 g of K2HPO4.
3H2O, 2.95 g of KH2PO4, 1.05 g of (NH4)2SO4, 0.10 g of
MgSO4.7H2O, 0.28 mg of FeSO4.7H2O, 7.1 mg of Ca(NO3)2.
4H2O, 4 mg of thiamine, 4 g of glucose and 50 mg of required
amino acids, per litre pH 7.0 at 28°C. Due to the use of
temperature-sensitive strains, 28°C was used as standard
growth temperature. LMC500, LMC510, LMC531 required
lysine, PA340, and PA340-678 required arginine, asparagine,
glutamine, threonine, histidine and leucine, for growth in
minimal medium. LMC509 was grown in a low-salt glucose
minimal medium (1/2 GB1), containing the same ingredients
as GB1 but differing in the amount of salt, which is 1.33 g of
K2HPO4.3H2O and 1.48 g of KH2PO4 per litre, pH 7.0.
To induce ﬁlamentation by inhibiting PBP3, cultures were
supplemented with 1 mg l
-1 aztreonam (ICN Biomedicals,
Ohio) (freshly resolved in a saturated Na2CO3 solution) at an
optical density at 450 nm (OD450) of 0.025. Prior to harvesting,
growth was continued for 2 MDs of the cells in the presence
of this antibiotic.
All E. coli strains were grown at various temperatures
(28°C, 37°C or 42°C) in rich medium containing 10 g bactot-
ryptone, 5 g yeast extract, 5 g NaCl, 15 mmol NaOH per litre
(TY). When required (see Table 1) 25–50 mgm l
-1 kanamycin,
100 mgm l
-1 ampicillin or 50 mgm l
-1 chloramphenicol was
added to the medium. Absorbance was measured at 450 nm
(minimal medium) and 600 nm (rich medium) with a 300-T-1
spectrophotometer (Gilford Instruments Laboratories).
Extraction of MurG and MreB from the IMVs
To study the nature of the interaction between MurG, MreB
and the inner membrane of E. coli, inside-out IMVs were
subjected to a variety of chemical reagents. IMVs were pre-
Fig. 8. Schematic representation of the possible constituents of the
putative cell elongation complex in E. coli. MraY, MurG and MreB
interact with the MreCD. The complex of MreBCD, PBP2 and RodA
was published by Kruse et al. (2005). As MreC was shown to
interact with three of the four high-molecular-weight class A PBPs
of B. subtilis (Van den Ent et al., 2006), it was postulated that
PBP1A could be part of the complex (see Discussion). For
simplicity only one MurG molecule is illustrated. However, the
possibility of formation of dimmers that might be part of the
complex is not excluded.
Table 1. Bacterial strains.
Strain/plasmid Relevant genotype Source
LMC500 (MC4100lysA) F
-, araD139, D(argF-lac)U169, deoC1, ﬂbB5301, ptsF25, rbsR, relA1, rpsL150,
lysA1
Taschner et al. (1988a)
LMC509 MC4100lysA, ftsZ84(Ts) Taschner et al. (1988a)
LMC510 MC4100lysA, ftsI2158(Ts) Taschner et al. (1988a)
LMC531 MC4100lysA, ftsQ1(Ts) Taschner et al. (1988a)
GS58 F
-, his, leu, thyA, deo, ara(Am), lac-125(Am), galU42 (Am), galE, tyrT [murG(Am)
supF-A81(Ts)
Salmond et al. (1980)
BW25113-DmraY/pMAKmraYec MraY-b-lactamase-His tag fusion expressing strain A. Bouhss
PA340 F
- argH1, thr
-, leuB6, gdH1, hisG1, gltB3, thi-1, lacY1, gal-6, Xyl-7, ara-14, Mtl-2,
malA1, rspL9, tonA2
Wachi et al. (1987)
PA340-678 PA340 gltB
+ Dmre-678 Wachi et al. (1987)
PA340-678 pMEW1 PA340 gltB
+ Dmre-678,K m
R pMEW1 expresses MreC and MreD constitutively M. Wachi
BL21(DE3)/pLysS F
-, ompT, hsdsB,( rB
-, mB
-, gal, dcm(DE3), Cm
R Novagen
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diluted in buffer L (50 mM triethanolamine acetate pH 7.5,
250 mM sucrose, 1 mM DTT) to a ﬁnal volume of 50 ml and
supplemented with 10 mM EDTA, 2 M NaCl, 6 M urea, or 1%
Triton X-100. All treatments were carried out on ice. The
inﬂuence of pH on the interaction between the proteins and
the inner membrane was investigated by incubating the IMVs
in 0.1 M Na2CO3 pH 11.5 in distilled water supplemented with
250 mM sucrose, 1 mM DTT and 0.5 mM PMSF for 60 min
on ice.After centrifugation, pellets were resuspended in 25 ml
sample buffer.
A sample of 40 mg (ﬁnal protein concentration) IMV diluted
in a ﬁnal volume of 50 ml buffer L was digested by trypsin
( 1 0Um l
-1). After incubation on ice for 60 min the digestion
was stopped by the addition of 4 vols ice-cold acetone, fol-
lowed by precipitation of the proteins at -70°C for 30 min. The
pellets were resuspended in 25 ml sample buffer. Subse-
quently, the presence of both proteins after all treatments was
assessed by SDS-PAGE and immunoblotting.
Expression and puriﬁcation of His-MreB MurG-His and
production of the antibodies
To construct the His-MreB and His-MurG fusion, the coding
sequence was ampliﬁed from the E. coli K12 chromosome
using the following primers: mreB1 (which introduced an NdeI
restriction site overlapping with the mreB initiation codon
5′-GGAATTCCATATGTTGAAAAAATTTC GTGGC-3′) and
mreB2 (which contains a BamHI restriction site 5′-CG
CGGATCCATTAC TCTTCGCTGAACAGGT-3′), murG1
(primer A) (5′-AAGAATTCATTAAAGAGGAGAGGTTCACG
ATGAGTGGTCAAGGAA-3′) (containing an EcoRI site in
bold) and murG2 (primer B) (5′-AAGGCAGATCTACAAT
TACGCCCGGGCAACCCGGC-3′) (containing a BglII site in
bold) for expression of MurG (Crouvoisier et al., 1999). The
MreB PCR product was digested with the corresponding
restriction enzymes and cloned into the vector pET28a
(Novagen) to yield plasmid pRMV1. Construction of MurG-
His generating plasmid pDMC3 was described by Crouvoisier
et al. (1999). E. coli strain BL21(DE3)/pLysS was trans-
formed with the plasmid pRMV1. This strain was grown at
37°C in TY medium supplemented with 50 mgm l
-1 of kana-
mycin and chloramphenicol to an OD600 of 0.4 and expression
of the proteins was induced with 1 mM IPTG. The strain
JM109 transformed with the plasmid pDMC3 was grown at
the same temperature and medium but in the presence of
100 mgm l
-1 ampicillin and the induction was carried out with
100 mM IPTG. Growth was continued for 4 h. Cells were
harvested by centrifugation and resuspended in ice-cold
buffer A (20 mM Tris-HCl, 500 mM NaCl, 5 mM imidazole,
pH 7.8). The bacteria for production of His-MreB were lysed
by passing twice through a French press at the pressure of
8000 psi and subsequently centrifuged for 30 min at 20 000 g
at 4°C. The JM109 (pDMC3) bacteria were passed three
times in a French press at 1100 psi at room temperature. The
proteins recovered in the supernatant were puriﬁed by
Ni-affinity chromatography using His-Bind resin (Novagen)
equilibrated with buffer A. The proteins were eluted with a
stepwise increasing concentration of imidazole ranging from
20 to 400 mM in a 20 mM Tris-HCl and 500 mM NaCl, pH 7.8,
buffer. His-tagged protein was recovered in fractions eluting
between 100 and 400 mM imidazole. Imidazole was removed
by gel ﬁltration and pure proteins were obtained. Integrity and
purity of the protein was checked by SDS-12% PAGE. The
protein concentration of the isolated His-tagged proteins was
determined with the BCA reagent kit (Pierce, Rockford, IL,
USA) according to the manufacturer’s protocol. The fractions
with the highest purity were used for rabbit immunization and
antibody production. The anti-MreB and anti-MurG sera were
affinity-puriﬁed (see below) using puriﬁed His-MreB or MurG-
His protein respectively.
Affinity puriﬁcation of antibodies
Antisera against MurG were generated by immunizing rabbits
by AgriSera (Sweden) with 0.1 mg ml
-1 montenide-diluted
protein solutions. The antisera were then affinity-puriﬁed. In
brief, pure protein (10 mg) was loaded on SDS-PAGE and
subsequently bound to nitrocellulose membrane. After block-
ing with 5% skim milk for at least 1 h, the membrane was
incubated overnight with 100 ml antiserum at 4°C. Next, the
membrane was washed three times with PBS (each time for
5 min) and incubated with 60 ml 0.1 M glycine pH 2.5. After
10 min incubation with vigorous agitation the eluted affinity-
puriﬁed antibodies were supplemented with 8 ml 1 M Tris
pH 9.5 to neutralize the pH and 5% BSA.
Construction of the MraY–b-lactamase–His fusion
The E. coli mraY gene in fusion with b-lactamase gene was
ampliﬁed from plasmid pAYEB16 (Bouhss et al., 1999) by
PCR with the primers 5′-AGGAACATGTTAGTTT GGC
TGGCCG-3′ and 5′-GTCGGATCCAAGCTTAATGGTGATG
GTGATGGTGCCAATG CTTAATCAGTGAGGC-3′ using the
Expand high ﬁdelity polymerase system (Roche Applied
Science). The PCR product was cut with BspLU11I and
BamHI (in bold) and inserted into the compatible sites NcoI
and BamHI of the pET28b vector (Novagen), generating
plasmid pETAYEB. In this construct the mraY gene was
expressed under control of a strong IPTG-inducible promoter,
and the encoded MraY-b-lactamase protein carried a
C-terminal His6 extension. This construct was veriﬁed by DNA
sequencing and then transformed to a strain deleted from the
mraY gene to yield the strain BW25113DmraY/pMAKmraYec
(to be published elsewhere by Bouhss et al.)
Immunoﬂuorescence microscopy
Fixation and permeabilization of the cells. The cells were
ﬁxed and permeabilized for immunolabelling essentially as
described by Den Blaauwen et al. (2003). The cells were
incubated with the primary antibody at 37°C for 1 h. Incuba-
tion with the secondary antibody Cy3-conjugated Donkey
Anti-Rabbit IgG (Jackson ImmunoResearch Laboratories,
USA) was carried out at 37°C for 30 min followed by visual-
ization by ﬂuorescence microscope.
Image analysis. Before analysis, cells were ﬁrst immobilized
on 1% agarose as described by Koppelman et al. (2004).
Phase contrast and ﬂuorescence images were obtained
using an Olympus BX60 ﬂuorescence microscope, equipped
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ﬁlter, 530–550 nm). Cell length was determined in phase
contrast images. The localization and intensity of the ﬂuores-
cence signal were analysed in the ﬂuorescence images of the
bacteria using the program Object-Image 2.13 (http://simon.
bio.uva.nl/object-image.html). The proﬁles were normalized
to the same length and then averaged.
Immunoprecipitation and cross-linking
Immunoprecipitation was performed with magnetic Dyna-
beads Protein A (Invitrogen) as speciﬁed by the
manufacturer. To this end, 100 ml of membrane fraction was
ﬁrst treated with 1% Triton X-100 for 1 h on ice, then chemi-
cally cross-linked to DSP (Pierce, Rockford, IL, USA)
(0.25 mg ml
-1), unless otherwise stated. After incubation at
4°C for at least 2 h, the reaction was stopped by adding 0.2 M
ammonium acetate or 50 mM Tris, pH 7.5. In parallel control
experiments were performed where chemical cross-linking
was omitted from the procedure (as described above) after
subjecting the membranes to Triton X-100.
Protein A beads (50 ml) were added to 10 ml of polyclonal
anti-MurG or anti-MreB affinity-puriﬁed antibodies and incu-
bated at room temperature for 2 h with rotational mixing.After
removal of unbound IgG, this protein A beads suspension
was added to the membrane sample and then incubated with
rotational mixing overnight at 4°C. Antibody–protein com-
plexes bound to the beads were pelleted by centrifugation
and washed three to ﬁve times with 1 ml PBS.
Fifty microlitres of SDS-PAGE sample buffer [5 mM Tris-
HCl pH 6.8, 1% (w/v) glycerol, 0.001% bromophenol blue]
without b-mercaptoethanol was added to the beads and the
mixture was incubated at 37°C for 5 min. To cleave the cross-
linker, 10% b-mercaptoethanol was included in the sample
buffer. After centrifugation the supernatant was analysed by
SDS-PAGE and immunoblotting.
Immunoblotting
Samples were separated on SDS-12% polyacrylamide gel
and transferred to nitrocellulose membrane. Membranes
were incubated with antibodies at a dilution of 1:10 000 in Tris
Buffered Saline containing 50 mM Tris, 150 mM NaCl, 0.05%
Tween, pH 7.5 (TBST). The secondary antibody was goat
anti-rabbit IgG conjugated to horseradish peroxidase (Bio-
Rad Laboratories, France) and used at a dilution of 1:10 000
in TBST. Detection was performed with a chemiluminescent
plus kit of Amersham Sciences followed by exposure to
Hyperﬁlm (Amersham Biosciences, UK Limited, England).
Quantiﬁcation of MurG by immunoblotting
To determine the number of MurG molecules per cell, E. coli
was grown to steady state in GB1 medium and harvested by
centrifugation. Pellets were then resuspended in sample
buffer and analysed on SDS-PAGE. In parallel a concentra-
tion range of 4–16 ng of puriﬁed MurG protein was made. Cell
number was determined by viable count. A serial dilutions of
bacteria grown in GB1 medium was plated and the number of
colonies after 24 h of growth at 28°C was counted. Proteins
of the cell extract and the MurG concentration range were
separated by 12% polyacrylamide gel electrophoresis and
transferred to a nitrocellulose membrane. The membranes
were incubated with anti-MurG antibody solution for 1 h at
room temperature. After washing and incubation with horse-
radish peroxidase-conjugated antibodies, a chemilumines-
cent plus kit (as described above) was used to visualize the
bands. The amount of MurG was densitometrically deter-
mined in the cell extracts and was compared with the stan-
dard curve made with different amounts of pure MurG protein
using the program Object-Image 2.13.
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Supplementary material
The following supplementary material is available for this
article:
Fig. S1. Extraction of MurG from IMVs of E. coli (LMC500).
IMVs were incubated in buffer L (see Experimental proce-
dures) and supplemented with the indicated chemical
reagents for 1 h on ice. After centrifugation, the pellets were
resuspended in sample buffer and analysed by SDS-PAGE
and immunoblotting with affinity-puriﬁed anti-MurG.
Fig. S2. Standard curve used to estimate the number of
MurG molecules per E. coli cell. A concentration gradient (4,
8 and 16 ng) of puriﬁed MurG was made and analysed on
immunoblot. The optical density was determined using the
program Object-Image 2.13. The x-axis represents the con-
centration of MurG. On the y-axis the optical density is given.
The results are the average of three independent experi-
ments (SD = 33, R
2 = 0.9728).
Fig. S3. Immunoblot analysis of the soluble and membrane-
bound fractions of MurG in wild-type (WT) E. coli and in the
DmreBCD deletion mutant strain. Membrane (M) and cytoso-
lic (C) fractions were prepared from wild-type (LMC500) and
DmreBCD mutant PA340-678 cells. The same amount of
proteins from these fractions was analysed on SDS-PAGE.
The immunoblot was probed with anti-MurG. In WT cells
MurG is membrane-bound. A very faint band is also visible in
the cytoplasmic fraction. In the DmreBCD deletion mutant
strain, MurG is mostly detected in the membrane fraction but
is also present in the cytolsolic fraction. The ratio of the
amount of MurG present in membrane and cytosolic fractions
was densitometrically estimated to be 6.8 in the WT and 3.4
in the DmreBCD deletion mutant cells.
Fig. S4. Localization of MurG in the PBP3(Ts) strain
LMC510 (A), FtsQ(Ts) strain LMC531 (B), and in the wild-
type E. coli strain LMC500 in the presence of aztreonam (C).
LMC531 and LMC510 cells were grown to steady state at
28°C in GB1 medium and then shifted to 42°C and grown for
2 MDs. LMC500 cells were grown at 28°C in GB1 after which
aztreonam was added and growth continued for 2°MDs.
Thereafter all cells were ﬁxed, permeabilized and immunola-
belled with antibodies directed against MurG. LMC531 and
LMC510 ﬁlaments showed no mid-cell localization of MurG,
whereas in aztreonam-induced ﬁlaments a clear mid-cell
localization is visible (see arrows). MurG mid-cell localization
was also absent in the FtsW(Ts) strain (data not shown).
Scale bar equals 1 mm.
Fig. S5. Assessment of background binding of the second-
ary antibodies used for the detection of the immunoblots
depicted in Fig. 4 (A and B). During this procedure the
primary antibodies were omitted from the procedure. As
depicted here no protein bands are visible.
Fig. S6. Localization of MreB in wild-type PA340 (A) and in
the DmreBCD mutant PA340-678 (B) cells. As described in
Experimental procedures these cells were grown to mid-
exponential phase at 28°C in TY medium. Thereafter cells
were ﬁxed, permeabilized and immunolabelled with antibod-
ies directed against MreB. In the strain PA340, MreB localizes
in a typical helical pattern. This pattern is not visible in the
deletion mutant. Phase contrast (left) and ﬂuorescence
images (right) are shown. Scale bar equals 1 mm.
Fig. S7. MurG localization is independent of the spherical
cell morphology. LMC500 cells were grown for 2 MDs in the
presence of mecillinam (inhibitor of PBP2), at 28°C in TY.
Cells were immunolabelled with anti-MurG. In these spherical
cells MurG localized normally as multiple foci in the cell
envelope. Phase contrast (left) and ﬂuorescence images
(right) are shown. Scale bar equals 1 mm.
This material is available as part of the online article from:
http://www.blackwell-synergy.com/doi/abs/10.1111/
j.1365-2958.2007.05851.x
(This link will take you to the article abstract).
Please note: Blackwell Publishing is not responsible for the
content or functionality of any supplementary materials sup-
plied by the authors. Any queries (other than missing mate-
rial) should be directed to the corresponding author for the
article.
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